Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging

Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine... Eur J Nucl Med Mol Imaging (2017) 44:1777–1778 DOI 10.1007/s00259-017-3682-8 LETTER TO THE EDITOR Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging 1 1 2 Giovanni Paganelli & Maddalena Sansovini & Emanuela Scarpi Received: 14 March 2017 /Accepted: 15 March 2017 /Published online: 22 March 2017 Springer-Verlag Berlin Heidelberg 2017 Dear Sir, 10 (31%) had a score of 3. Among the 23 FDG PET-negative We would like to thank Zanotti-Fregonara et al. for their in- patients, 12 (52%) showed a score of 4 and 11 (48%) a score teresting letter about our recent study, BLong-term follow-up of 3. Pre-therapy and post-therapy SRI values were and role of FDG PET in advanced pancreatic neuroendocrine concordant. The statistical analysis of our data revealed that the uptake patients treated with 177Lu-DOTATATE^, published in the March 2017 issue [1]. In addition to the positive comments level of SRI was not significant in terms of progression-free on the importance of dual-tracer imaging, Zanotti-Fregonara survival (PFS) and so the SRI uptake value was not included et al. raise the question as to whether the uptake level in in the univariate-multivariate analysis and thus not in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Nuclear Medicine and Molecular Imaging Springer Journals

Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging

Loading next page...
 
/lp/springer_journal/reply-to-predicting-the-outcome-of-peptide-receptor-radionuclide-xYby0YT6DY
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1619-7070
eISSN
1619-7089
D.O.I.
10.1007/s00259-017-3682-8
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial